Resources from the same session
YOSEMITE: A 3 Arm Double-Blind Randomized Phase 2 Study of Gemcitabine, Paclitaxel Protein-Bound Particles for Injectable Suspension (Abraxane®) and Placebo (GAP) versus Gemcitabine, Abraxane® and either 1 or 2 Truncated Courses of Demcizumab (GAD).
Presenter: Antonio Cubillo Gracian
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Protein biomarkers as predictors of outcome with regorafenib (REG) in patients (pts) with hepatocellular carcinoma (HCC) in the RESORCE trial
Presenter: Michael Teufel
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
New promising combination therapy of a mitochondrial metabolism inhibitor with mFOLFIRINOX in pancreatic cancer
Presenter: Angela Alistar
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
nab-Paclitaxel (nab-P) Plus Gemcitabine (G) for Patients (Pts) With Locally Advanced Pancreatic Cancer (LAPC): Interim Efficacy and Safety Results From the Phase 2 LAPACT Trial
Presenter: Philip Philip
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Invited Discussant 1733PD and 1734PD
Presenter: Eric Van Cutsem
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Gastrointestinal tumours, non-colorectal: Invited Discussant 626PD and 627PD
Presenter: Yoon-Koo Kang
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Gastrointestinal tumours, non-colorectal: Invited Discussant 624PD and 625PD
Presenter: David Cunningham
Session: Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Comparison of the eighth and seventh editions of the American Joint Committee on Cancer TNM staging systems for gastric cancer: proposal for a simplified and improved TNM staging system
Presenter: Junpeng Lin
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Anti-CTGF human recombinant monoclonal antibody pamrevlumab increases resectability and resection rate when combined with gemcitabine/Nab-paclitaxel in the treatment of locally advanced pancreatic cancer patients
Presenter: Ewa Carrier
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
A randomized phase III trial comparing 4 courses and 8 courses of S-1 adjuvant chemotherapy for p-stage II gastric cancer: JCOG1104 (OPAS-1)
Presenter: Takaki Yoshikawa
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.